Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

被引:0
作者
Alexander Karachunskiy
Gesche Tallen
Julia Roumiantseva
Svetlana Lagoiko
Almira Chervova
Arend von Stackelberg
Olga Aleinikova
Oleg Bydanov
Lyudmila Bajdun
Tatiana Nasedkina
Natalia Korepanova
Sergei Kuznetsov
Galina Novichkova
Marina Goroshkova
Dmitry Litvinov
Natalia Myakova
Natalia Ponomareva
Evgeniya Inyushkina
Konstantin Kondratchik
Julia Abugova
Larisa Fechina
Oleg Arakaev
Alexander Karelin
Vladimir Lebedev
Natalia Judina
Gusel Scharapova
Irina Spichak
Anastasia Shamardina
Olga Ryskal
Alexander Shapochnik
Alexander Rumjanzew
Joachim Boos
Günter Henze
机构
[1] Federal Research Centre of Pediatric Hematology,Department of Oncology, Hematology and Radiotherapy
[2] Oncology and Immunology,Department of Pediatric Oncology/Hematology
[3] Pirogov Russian National Research Medical University,Department of Pediatric Oncology/Hematology
[4] Charité-Universitätsmedizin Berlin,Department of Paediatrics, Cumming School of Medicine, Faculty of Medicine
[5] Universitätsklinikum Hamburg-Eppendorf,Department of Pediatric Hematology
[6] University of Calgary,Department of Pediatric Hematology
[7] Republic Clinical Research Centre for Pediatric Oncology and Hematology,Paediatric Oncohematological Centre
[8] Russian Children Clinical Hospital,Department of Pediatric Oncology/Hematology
[9] National Research University Higher School of Economics,Department of Pediatric Oncology/Hematology
[10] Municipal Children,Department of Pediatric Oncology/Hematology
[11] s Clinical Hospital,Paediatric Oncohematological Centre
[12] Moscow Regional Oncological Dispensary,Department of Pediatric Hematology
[13] Morozov Children’s Hospital,Department of Pediatric Oncology/Hematology
[14] Regional Children’s Hospital,Department of Pediatric Oncology/Hematology
[15] Regional Children’s Hospital,Department of Pediatric Hematology and Oncology
[16] Regional Children’s Hospital,Institute of Oncology, Radiology and Nuclear Medicine
[17] Regional Children’s Hospital,undefined
[18] Regional Children’s Hospital,undefined
[19] Regional Children’s Hospital,undefined
[20] Regional Children’s Hospital,undefined
[21] Regional Oncological Hospital,undefined
[22] University Children’s Hospital Muenster,undefined
[23] Dmitry Rogachev National Research Center of Pediatric Hematology,undefined
[24] Oncology and Immunology,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词
Acute lymphoblastic leukemia; Children; Native ; -derived asparaginase; Multicenter trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1001 / 1012
页数:11
相关论文
共 163 条
[1]  
Abbott LS(2015)Allergic reactions associated with intravenous versus intramuscular pegaspargase: a retrospective chart review Paediatr Drugs 17 315-321
[2]  
Zakova M(2001)Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries Br J Clin Pharmacol 52 433-437
[3]  
Shaikh F(2016)The Incidence of hypersensitivity reactions to pegylated asparaginase in children with acute lymphoblastic leukemia: a city-wide experience J Pediatr Hematol Oncol 38 e16-e20
[4]  
Shewaramani N(2015)Asparaginase pharmacokinetics and implications of therapeutic drug monitoring Leuk Lymphoma 56 2273-2280
[5]  
Punnett A(1993)Comparative pharmacokinetic studies of three asparaginase preparations J Clin Oncol 11 1780-1786
[6]  
Dupuis LL(2017)Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection—a review Leuk Lymphoma 58 766-772
[7]  
Albertsen BK(1996)Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations Eur J Cancer 32A 1544-1550
[8]  
Schroder H(1986)Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia N Engl J Med 315 657-663
[9]  
Jakobsen P(2002)Comparison of Blood 99 2734-2739
[10]  
Muller HJ(2015)-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children’s Leukemia Group phase 3 trial Pediatr Blood Cancer 62 427-433